BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20589654)

  • 1. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
    Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.
    Reid S; Renwick A; Seal S; Baskcomb L; Barfoot R; Jayatilake H; Pritchard-Jones K; Stratton MR; Ridolfi-Lüthy A; Rahman N; ;
    J Med Genet; 2005 Feb; 42(2):147-51. PubMed ID: 15689453
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited FANCD1/BRCA2 exon 7 splice mutations associated with acute myeloid leukaemia in Fanconi anaemia D1 are not found in sporadic childhood leukaemia.
    Barber LM; Barlow RA; Meyer S; White DJ; Will AM; Eden TO; Taylor GM
    Br J Haematol; 2005 Sep; 130(5):796-7. PubMed ID: 16115142
    [No Abstract]   [Full Text] [Related]  

  • 5. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
    Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
    Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia and solid malignancies in childhood: a national retrospective study.
    Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F
    Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
    Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
    Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
    Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.
    Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G
    Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple synchronous tumors in a child with Fanconi anemia.
    Compostella A; Toffolutti T; Soloni P; Dall'Igna P; Carli M; Bisogno G
    J Pediatr Surg; 2010 Feb; 45(2):e5-8. PubMed ID: 20152336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.